MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.56
-0.01 (-0.06%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MediWound Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MediWound stock has a target of 36, which predicts an increase of 117.39% from the current stock price of 16.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 21, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for MediWound is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $31 → $36 | Strong Buy | Maintains | $31 → $36 | +117.39% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +87.20% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +50.97% | Mar 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +135.51% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +50.97% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
25.26M
from 16.96M
Increased by 48.92%
Revenue Next Year
34.11M
from 25.26M
Increased by 35.04%
EPS This Year
-2.81
from -2.10
EPS Next Year
-2.08
from -2.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 26.6M | 36.2M | ||||||
| Avg | 25.3M | 34.1M | ||||||
| Low | 23.6M | 31.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 56.8% | 43.2% | ||||||
| Avg | 48.9% | 35.0% | ||||||
| Low | 39.1% | 26.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -2.22 | -1.47 | |||||
| Avg | -2.81 | -2.08 | |||||
| Low | -3.24 | -2.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.